| Filed On | Filing |
|---|---|
| 10 Nov 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, Mass. – November 10, 2026 – 908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety, and defense tech applications, today reported fi... |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
Updated full year 2026 outlook reflects 21% to 25% year-over-year growth |
| 08 Jul 2026 |
8-K: Other Events
On July 8, 2026, 908 Devices Inc. (the “Company”) issued an aggregate of 3,213,583 shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), in satisfaction of its obligations with respect to the Earnout Consider... |
| 12 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On June 11, 2026, 908 Devices Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). As of April 16, 2026, the record date for the 2026 Annual Meeting, there were 37,446,534 shares of the Company’s... |
| 06 May 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE 908 DEVICES INC. HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO 908 DEVICES INC. I... |
| 03 Mar 2026 |
8-K: Results of Operations and Financial Condition
Fourth quarter 2025 revenue increased 21% compared to prior year |
| 20 Jan 2026 |
8-K: Results of Operations and Financial Condition
Preliminary full year 2025 revenue of approximately $56 million, representing ~17% growth year-over-year |
| 10 Nov 2025 |
8-K: Results of Operations and Financial Condition
Year-to-date revenue increased 16% while Adjusted EBITDA loss improves 53% quarter over quarter |
| 05 Aug 2025 |
8-K: Results of Operations and Financial Condition
Revenue from continuing operations grew 14% compared to prior year |
| 04 Aug 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors |
| 16 Jun 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
BOSTON, June 16, 2025 – 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation ... |
| 13 Jun 2025 |
8-K: Submission of Matters to a Vote of Security Holders
On June 12, 2025, 908 Devices Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”). As of April 17, 2025, the record date for the 2025 Annual Meeting, there were 35,739,753 shares of the Company’s... |
| 13 May 2025 |
8-K: Results of Operations and Financial Condition
Revenue from continuing operations grew 59% compared to prior year, driven by an increase in product and service revenue |
| 04 Mar 2025 |
8-K: Results of Operations and Financial Condition
Divested desktop portfolio to Repligen for $70 million, including the MAVEN, MAVERICK, REBEL and ZipChip products |
| 04 Mar 2025 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
EXHIBIT C – Bill of Sale and Assignment and Assumption Agreement |
| 12 Nov 2024 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
Revenue increases 17% compared to prior year, driven by recently acquired handheld products |
| 30 Aug 2024 |
8-K: Regulation FD Disclosure
On August 30, 2024, 908 Devices Inc. (“908 Devices”) posted an updated Investor Presentation on its investor relations website at ir.908devices.com. Members of 908 Devices’ management will use the presentation in connection with meetings... |
| 06 Aug 2024 |
8-K: Results of Operations and Financial Condition
Revenue increases 16% compared to prior year, driven by newly acquired handheld products |
| 25 Jun 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
908 Devices Appoints Michele M. Leonhart, Former Administrator of the United States Drug Enforcement Administration (DEA), to its Board of Directors |
| 14 Jun 2024 |
8-K: Submission of Matters to a Vote of Security Holders
On June 13, 2024, 908 Devices Inc. (the “Company”) held its 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”). As of April 19, 2024, the record date for the 2024 Annual Meeting, there were 32,983,276 shares of the Company’s... |
Loading...